Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact
Go back to Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact| PANDORA MEDIA, Inc. (NYSE: P) | Delayed: 129.40 +3.40 (2.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.00 | 52 Week High | $16.23 | |||
| Open | $124.60 | 52 Week Low | $7.10 | |||
| Day High | $130.88 | P/E | N/A | |||
| Day Low | $124.60 | EPS | $-0.15 | |||
| Volume | 4,699,677 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.72 +0.05 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.67 | 52 Week High | $37.39 | |||
| Open | $28.62 | 52 Week Low | $28.25 | |||
| Day High | $28.87 | P/E | 17.41 | |||
| Day Low | $28.39 | EPS | $1.65 | |||
| Volume | 24,935,558 | |||||
